Fox James 4/A
4/A · Biota Pharmaceuticals, Inc. · Filed May 6, 2013
Insider Transaction Report
Form 4/AAmended
Fox James
Director
Transactions
- Award
Common Stock
2013-05-01+8,700→ 8,700 total
Holdings
- 30,614(indirect: Penashe Holdings Propriety Limited)
Common Stock
Footnotes (3)
- [F1]These restricted stock units vest in 12 equal monthly installments commencing on June 1, 2013.
- [F2]The original Form 4 report filed on May 3, 2013 incorrectly reported a grant to the Reporting Person of an option to purchase 15,000 shares of common stock instead of an equivalent grant of RSUs for 8,700 shares of common stock. The Reporting Person was granted RSUs instead of options based on the Reporting Person's country of residency.
- [F3]Mr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities to the extent of any indirect pecuniary interest in his distributive shares therein.